Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
PARSIPPANY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
Advances Pacira’s “5x30” path to becoming an innovative biopharmaceutical organization -- -- Adds novel, high-capacity, local ...
Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help ...
Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving closer to approval. The opioid epidemic in the ...
While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
Leaders with Project Opioid, a non-profit established after the opioid epidemic was declared a public health emergency in 2017, said the trend of declining overdose deaths is encouraging, but there is ...
One way to address the opioid crisis is to clear away red tape and make other pain treatments more easily available, Rep. Melanie Stinnett writes.
The Drug Enforcement Administration finds Alabamians threw away more than 3,500 pounds of prescription drugs during Drug Take Back Day. That was in October 2024. But drug prevention advocates believe ...
A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial. Neurotrophin-3 (NT-3 ...